| Radiomics: extracting more information from medical images using advanced feature analysis P Lambin, E Rios-Velazquez, R Leijenaar, S Carvalho, ... European Journal of Cancer 48 (4), 441-446, 2012 | 4522 | 2012 |
| Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach HJWL Aerts, ER Velazquez, RTH Leijenaar, C Parmar, P Grossmann, ... Nature communications 5, 2014 | 4420 | 2014 |
| Robust radiomics feature quantification using semiautomatic volumetric segmentation C Parmar, ER Velazquez, R Leijenaar, M Jermoumi, S Carvalho, RH Mak, ... PloS one 9 (7), e102107, 2014 | 606 | 2014 |
| Breast Cancer Risk Genes—Association Analysis in More than 113,000 Women Breast Cancer Association Consortium New England Journal of Medicine, 2021 | 534 | 2021 |
| Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability RTH Leijenaar, S Carvalho, ER Velazquez, WJC Van Elmpt, C Parmar, ... Acta Oncologica 52 (7), 1391-1397, 2013 | 444 | 2013 |
| The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis RTH Leijenaar, G Nalbantov, S Carvalho, WJC van Elmpt, EGC Troost, ... Scientific reports 5, 2015 | 431 | 2015 |
| External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma RTH Leijenaar, S Carvalho, FJP Hoebers, HJWL Aerts, WJC van Elmpt, ... Acta Oncologica 54 (9), 1423-1429, 2015 | 222 | 2015 |
| Rapid Learning health care in oncology’–An approach towards decision support systems enabling customised radiotherapy P Lambin, E Roelofs, B Reymen, ER Velazquez, J Buijsen, CML Zegers, ... Radiotherapy and Oncology 109 (1), 159-164, 2013 | 211 | 2013 |
| Decision Support Systems for Personalized and Participative Radiation Oncology P Lambin, J Zindler, B Vanneste, L Van De Voorde, D Eekers, I Compter, ... Advanced Drug Delivery Reviews, 2016 | 143 | 2016 |
| Is there a causal relationship between genetic changes and radiomics-based image features? An in vivo preclinical experiment with doxycycline inducible GADD34 tumor cells KM Panth, RTH Leijenaar, S Carvalho, NG Lieuwes, A Yaromina, ... Radiotherapy and Oncology 116 (3), 462-466, 2015 | 135 | 2015 |
| Modern clinical research: How rapid learning health care and cohort multiple randomised clinical trials complement traditional evidence based medicine P Lambin, J Zindler, B Vanneste, L van de Voorde, M Jacobs, D Eekers, ... Acta Oncologica 54 (9), 1289-1300, 2015 | 72 | 2015 |
| 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC)–A prospective … S Carvalho, RTH Leijenaar, EGC Troost, JE van Timmeren, C Oberije, ... PloS one 13 (3), e0192859, 2018 | 71 | 2018 |
| Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer S Carvalho, RTH Leijenaar, ER Velazquez, C Oberije, C Parmar, ... Acta Oncologica 52 (7), 1398-1404, 2013 | 52 | 2013 |
| Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes N Mavaddat, L Dorling, S Carvalho, J Allen, A González-Neira, R Keeman, ... JAMA oncology, 0 | 44 | |
| Prognostic value of blood-biomarkers related to hypoxia, inflammation, immune response and tumour load in non-small cell lung cancer - A survival model with external validation. S Carvalho, E Troost, J Bons, P Menheere, P Lambin, C Oberije Radiotherapy and Onocology, 2016 | 40 | 2016 |
| Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics JE van Timmeren, S Carvalho, RTH Leijenaar, EGC Troost, W van Elmpt, ... PloS one 14 (6), e0217536, 2019 | 38 | 2019 |
| Evaluating Tumor Response of Non-Small Cell Lung Cancer Patients With 18 F-Fludeoxyglucose Positron Emission Tomography: Potential for Treatment Individualization I Toma-Dasu, J Uhrdin, M Lazzeroni, S Carvalho, W van Elmpt, P Lambin, ... International Journal of Radiation Oncology* Biology* Physics 91 (2), 376-384, 2015 | 35 | 2015 |
| Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study A Antoniou, X Yang BMJ Publishing Group, 2022 | 29* | 2022 |
| Splicing predictions, minigene analyses and ACMG/AMP clinical classification of 42 germline PALB2 splice‐site variants A Valenzuela‐Palomo, E Bueno‐Martínez, L Sanoguera‐Miralles, ... The Journal of pathology, 2021 | 16 | 2021 |
| Breast cancer risks associated with missense variants in breast cancer susceptibility genes L Dorling, S Carvalho, J Allen, MT Parsons, C Fortuno, A González-Neira, ... medRxiv, 2021 | 13 | 2021 |
Philippe LambinProfessor of Precision Medicine, Maastricht UniversityAdresse e-mail validée de maastrichtuniversity.nl
